About Regeneron Pharmaceuticals

Regeneron Pharmaceuticals is a biopharmaceutical company that develops and commercializes medicines for the treatment of serious diseases, including eye disorders, cancer, and infectious diseases. The company's key products include Eylea, a treatment for age-related macular degeneration, and Libtayo, a skin cancer treatment. Regeneron's innovative therapies have improved the lives of millions of patients worldwide, solidifying its position as a leader in the biopharmaceutical industry.